The dual facets of B cell immunity: From pathogenic drivers to theranostic tools
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: T-cell and B-cell Immunology · Immunotherapy and Immune Responses · Cancer Immunotherapy and Biomarkers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. The contribution of Bruce Glick to the definition of the role played by the bursa of Fabricius in the development of the B cell lineage10.1111/j.1365-2249.2006.03131.x ↗
2. The development of B cells in the bone marrow is controlled by the balance between cell-autonomous mechanisms and signals from the microenvironment10.1084/jem.191.1.5 ↗
3. Mechanism of thymus-independent immunocyte triggering10.1084/jem.139.1.74 ↗
4. CpG motifs in bacterial DNA trigger direct B-cell activation10.1038/374546a0 ↗
5. Toll-like receptor stimulation as a third signal required for activation of human naive B cells10.1002/eji.200535744 ↗
6. Interleukin-6 is a growth factor for nonmalignant human plasmablasts10.1182/blood.V97.6.1817 ↗
7. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 610.1016/S1074-7613(03)00208-5 ↗
8. Immunoregulatory role of CD40 in human B cell differentiation10.4049/jimmunol.150.4.1276 ↗
9. Synergistic augmentative effect of interleukin-10 and CD27/CD70 interactions on B-cell immunoglobulin synthesis10.1046/j.1365-2567.1998.00521.x ↗
10. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells10.4049/jimmunol.175.12.7867 ↗
11. Standardizing flow cytometry immunophenotyping analysis from the human immunophenotyping consortium10.1038/srep20686 ↗
12. B cells are major players in cancer immunity10.1016/j.imlet.2025.107064 ↗
13. Isoformic PD-1 impedes B cell activation and function in HIV-1 infection
14. Immunological targets in generalized myasthenia gravis treatment: where are we going now?10.3390/brainsci15090978 ↗
15. Keratoconjunctivitis Sicca in Sjögren disease: diagnostic challenges and therapeutic advances10.3390/ijms26188824 ↗
16. Regulatory T cell therapy for Sjögren's disease: from pathogenesis to targeted treatment
17. Defects in antigen processing and presentation: mechanisms, immune evasion and implications for cancer vaccine development
18. Autoimmune diseases: molecular pathogenesis and therapeutic targets10.1002/mco2.70262 ↗
19. Chronic viral infection promotes efficient germinal center B cell responses10.1016/j.celrep.2019.12.023 ↗
20. B cell-T cell interplay in immune regulation: a focus on follicular regulatory T and regulatory B cell functions10.3389/fcell.2022.991840 ↗
21. T cell–B cell interactions in human autoimmune diseases10.1016/j.coi.2025.102539 ↗
22. The role of B lymphocyte subsets in nephrotic syndrome: functions, mechanisms, clinical significance and future perspectives10.3389/fimmu.2025.1598197 ↗
23. Frequency of Th17 CD20+ cells in the peripheral blood of rheumatoid arthritis patients is higher compared to healthy subjects10.1186/ar3541 ↗
24. Biomarkers in autoimmune diseases of the central nervous system
25. Treatment of nephrotic syndrome with anti-CD20 therapies in pregnancy: a case series and review of the literature10.1080/0886022X.2025.2481201 ↗
26. BAFF and APRIL counterregulate susceptibility to inflammation-induced preterm birth10.1016/j.celrep.2023.112352 ↗
27. Multiple sclerosis: molecular pathogenesis and therapeutic intervention10.1038/s41392-025-02415-4 ↗
28. The role of regulatory B cells in kidney diseases10.3389/fimmu.2021.683926 ↗
29. BTK inhibition limits B-cell-T-cell interaction through modulation of B-cell metabolism: implications for multiple sclerosis therapy10.1007/s00401-022-02411-w ↗
30. Engineering B cells to treat and study human disease10.1038/s41587-025-02757-y ↗
31. The link between antibodies to OxLDL and natural protection against pneumococci depends on D(H) gene conservation10.1084/jem.20121861 ↗
32. Targeting BCMA in multiple myeloma: a comprehensive review of immunotherapeutic strategies and clinical outcomes
33. B cell development and maturation10.1007/978-981-15-3532-1_1 ↗
34. B-cell biology and development10.1016/j.jaci.2013.01.046 ↗
35. Single-cell analysis identifies dynamic gene expression networks that govern B cell development and transformation10.1038/s41467-021-27232-5 ↗
36. An integrated multi-omic single-cell atlas of human B cell identity10.1016/j.immuni.2020.06.013 ↗
37. Single-cell analyses identify brain mural cells expressing CD19 as potential off-tumor targets for CAR-T immunotherapies10.1016/j.cell.2020.08.022 ↗
38. Comparative proteomic analysis to discover potential therapeutic targets in human multiple myeloma10.1002/prca.200900068 ↗
39. OMIP-003: phenotypic analysis of human memory B cells10.1002/cyto.a.21112 ↗
40. The regulatory roles of neutrophils in adaptive immunity10.1186/s12964-019-0471-y ↗
41. Dysregulated naive B cells and de novo autoreactivity in severe COVID-1910.1038/s41586-022-05273-0 ↗
42. The single-cell immune landscape of HIV-associated aggressive B-cell lymphoma
43. Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients10.1038/s41467-025-55823-z ↗
44. CD27(-)CD38(+) B cells accumulated in early HIV infection exhibit transitional profile and promote HIV disease progression10.1016/j.celrep.2021.109344 ↗
45. Whole-genome sequencing reveals three follicular lymphoma subtypes with distinct cell of origin and patient outcomes
46. B-1 B cell IgM antibody initiates T cell elicitation of contact sensitivity
47. CD1d(hi)CD5+ B cells expanded by GM-CSF in vivo suppress experimental autoimmune myasthenia gravis10.4049/jimmunol.1303397 ↗
48. B-cell depletion in autoimmune diseases. 83, 1409-1420, doi:10.1136/ard-2024-225727%J10.1136/ard-2024-225727 ↗
49. Diffuse large B cell lymphoma (DLBCL): epidemiology, pathophysiology, risk stratification, advancement in diagnostic approaches and prospects: narrative review10.1007/s12672-025-01958-w ↗
50. Regulatory T cells in homeostasis and disease: molecular mechanisms and therapeutic potential10.1038/s41392-025-02326-4 ↗
51. Regulatory B cells in autoimmune diseases: insights and therapeutic potential10.1016/j.jaut.2024.103326 ↗
52. Tertiary lymphoid structures and B cells: an intratumoral immunity cycle10.1016/j.immuni.2023.08.009 ↗
53. Post-translational modified neoantigens in autoimmune diseases: challenges of immune tolerance
54. Functional dissection of the granzyme family: cell death and inflammation10.1111/j.0105-2896.2010.00907.x ↗
55. Altered glucose metabolism in B cells: Implications for the pathogenesis and treatment of autoimmune diseases10.1016/j.jaut.2025.103472 ↗
56. Small colony variants and their role in biofilm associated infections10.1016/j.microb.2025.100538 ↗
57. Persistence of hepatitis B virus DNA and the tempos between virion secretion and genome maturation in a mouse model10.1128/JVI.01001-19 ↗
58. Effects of hepatitis B virus infection and strategies for preventing mother-to-child transmission on maternal and fetal T-cell immunity
59. Cellular and genetic restrictions in the immunoregulatory activity of alpha-fetoprotein. II. Alpha-fetoprotein-induced suppression of cytotoxic T lymphocyte development10.1084/jem.148.2.360 ↗
60. A single point mutation on FLT3L-Fc protein increases the risk of immunogenicity
61. B Cells in Rheumatoid Arthritis：Pathogenic Mechanisms and Treatment Prospects
62. Altered B cell signalling in autoimmunity10.1038/nri.2017.24 ↗
63. Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics10.1038/s41392-025-02168-0 ↗
64. Targeting CD40L: a Promising Therapeutic Approach10.1128/CDLI.11.4.635-641.2004 ↗
65. B cell-derived IL-6 promotes disease10.1038/nrrheum.2017.163 ↗
66. IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE10.1038/s41467-018-03750-7 ↗
67. Expansion of T follicular helper-T helper 1 like cells through epigenetic regulation by signal transducer and activator of transcription factors10.1136/annrheumdis-2017-212652 ↗
68. IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis10.1016/S0889-857X(05)70030-2 ↗
69. New insights into the immunopathogenesis of systemic lupus erythematosus: the role of T follicular helper cells
70. T Follicular Helper Cell Biology: A Decade of Discovery and Diseases10.1016/j.immuni.2019.04.011 ↗
71. Immune system dysregulation in the progression of multiple sclerosis: molecular insights and therapeutic implications10.1016/j.neuroscience.2024.04.004 ↗
72. Signal transducer and activator of transcription 3 hyperactivation associates with follicular helper T cell differentiation and disease activity in rheumatoid arthritis10.3389/fimmu.2018.01226 ↗
73. Abhishek Das, A.D. et al. IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. (2012).
74. Skin-stage schistosomula of schistosoma mansoni produce an apoptosis-inducing factor that can cause apoptosis of T cells*10.1074/jbc.M201344200 ↗
75. Epigenetic mechanisms underlying hiv-infection induced susceptibility of CD4+ T cells to enhanced activation-induced fasl expression and cell death10.1097/QAI.0000000000002526 ↗
76. Non-hodgkin lymphomas: malignancies arising from mature B cells10.1101/cshperspect.a034843 ↗
77. Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism10.1007/s00262-018-2269-y ↗
78. IL-10 derived from CD1dhiCD5+ B cells regulates experimental autoimmune myasthenia gravis10.1016/j.jneuroim.2015.10.023 ↗
79. The future is on the way: &♯x3b2; cell function preservation for type 1 diabetes10.1016/j.medj.2023.11.003 ↗
80. IL-10 signaling in dendritic cells controls IL-1β-mediated IFNγ secretion by human CD4+ T cells: relevance to inflammatory bowel disease10.1038/s41385-019-0194-9 ↗
81. Nanomedicine targeting the PD-1/PD-L1 axis in autoimmune diseases: breaking conventional barriers to restore immune tolerance10.1186/s12951-025-03766-4 ↗
82. Hepatitis B virus infection and the immune response: The big questions10.1016/j.bpg.2017.05.003 ↗
83. Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis10.1111/j.1749-6632.1987.tb51321.x ↗
84. An overview of systemic lupus erythematosus (sle) pathogenesis, classification, and management
85. B cell-derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity10.1084/jem.20170580 ↗
86. IL-10-producing regulatory B cells are decreased in patients with psoriasis10.1016/j.jdermsci.2015.11.003 ↗
87. Inflammatory stress induced by a combination of cytokines (IL-6, IL-17, TNF-α) leads to a loss of integrity on bEnd.3 endothelial cells in vitro BBB model10.1016/j.brainres.2020.146647 ↗
88. Anti-double stranded DNA antibodies: a rational diagnostic approach in limited-resource settings
89. B-cell receptor repertoire sequencing: deeper digging into the mechanisms and clinical aspects of immune-mediated diseases10.1016/j.isci.2022.105002 ↗
90. Autoantibodies in systemic lupus erythematosus: diagnostic and pathogenic insights10.3390/jcm14165714 ↗
91. Age-associated B cells indicate disease activity in rheumatoid arthritis10.1016/j.cellimm.2022.104533 ↗
92. Memory B cells in multiple sclerosis: emerging players in disease pathogenesis10.3389/fimmu.2021.676686 ↗
93. The CXCL13/CXCR5 immune axis in health and disease-implications for intrathecal B cell activities in neuroinflammation10.3390/cells11172649 ↗
94. Adhesion molecule expression in CD5-negative/CD10-negative chronic B-cell leukemias: comparison with non-Hodgkin's lymphomas and CD5-positive B-cell chronic lymphocytic leukemia10.1053/hupa.2001.20891 ↗
95. The progress in classification and prognosis evaluation of BCR::ABL1 positive acute lymphoblastic leukemia]
96. Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL10.1038/s41467-019-14081-6 ↗
97. Single-Cell RNA-seq and bulk RNA-seq reveal intratumoral heterogeneity and tumor microenvironment characteristics in diffuse large B-cell lymphoma
98. Longitudinal analysis of the human B cell response to ebola virus infection10.1016/j.cell.2019.04.036 ↗
99. Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak10.1126/science.aad5788 ↗
100. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies10.1038/s41564-020-00789-5 ↗